MedPath

Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children

Not Applicable
Conditions
Separation Anxiety Disorder
Social Anxiety Disorder
Generalized Anxiety Disorder
Interventions
Other: Attentional Bias Modification Treatment (ABMT) - Active
Other: Attentional Bias Modification Treatment - Placebo
Behavioral: Cognitive Behavioral Group Therapy
Behavioral: Psychoeducational Control Intervention
Registration Number
NCT01687764
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

The objective of this project is to test the combination of active or placebo Attentional Bias Modification Treatment (ABMT) to either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for anxiety disorders in children.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Primary diagnosis of Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SeAD) or Social Anxiety Disorder (SoAD) according to KSADS-PL psychiatric interview
Exclusion Criteria
  • Other psychiatric disorder that causes more impairment and suffering than GAD, SeAD or SoAD in the clinical evaluation
  • Current or previous treatment (behavioral or pharmacological) for a psychaitric disorder in childhood
  • IQ < 70 (Raven)

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
CBGT+ABMT(placebo)Cognitive Behavioral Group Therapy-
CBGT+ABMT(active)Attentional Bias Modification Treatment (ABMT) - Active-
CBGT+ABMT(placebo)Attentional Bias Modification Treatment - Placebo-
PCI+ABMT(active)Psychoeducational Control Intervention-
CBGT+ABMT(active)Cognitive Behavioral Group Therapy-
PCI+ABMT(active)Attentional Bias Modification Treatment (ABMT) - Active-
PCI+ABMT(placebo)Attentional Bias Modification Treatment - Placebo-
PCI+ABMT(placebo)Psychoeducational Control Intervention-
Primary Outcome Measures
NameTimeMethod
Clinical Global Impression - Improvement Scale (CGI-I) / dichotomousEndpoint (week-10) and 6-month follow-up

Percentage of subjects with less than 2 points in the CGI-I scale in week 10 and in 6-month follow-up

Pediatric Anxiety Rating Scale (PARS) / continuousEndpoint (week 10) and 6-month follow-up

Score change on Pediatric Anxiety Rating Scale (PARS) from baseline to week 10 and to 6-month follow-up

Secondary Outcome Measures
NameTimeMethod
Screen for Children and Anxiety Related Emotional Disorders (SCARED)Endpoint (week-10) and 6-months follow-up

Score change in SCARED child and parent versions from baseline to week 10 and 6-months follow-up

Childhood Depression Inventory (CDI)Endpoint (week-10) and 6-month follow-up

Score change in CDI from baseline to week-10 and to 6-month follow-up

Spence Children's Anxiety Scale (SCAS)Endpoint (week-10) and 6-month follow-up

Score change in SCAS from baseline to week-10 and to 6-month follow-up

Biological measuresEndpoint (week-10) and 6-month follow-up

Change in biological measures from baseline to week-10 and to 6-month follow-up

Swanson, Nolan, and Pelham scale - Version IV (SNAP-IV)Endpoint (week-10) and 6-month follow-up

Score change in SNAP-IV from baseline to week-10 and 6-month follow-up

Neuropsychological measuresEndpoint (week-10) and 6-month follow-up

Change in neuropsychological measures from baseline to week-10 and 6-month follow-up

Trial Locations

Locations (4)

Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA)

🇧🇷

Porto Alegre, Rio Grande do Sul, Brazil

National Institute of Mental Health (NIMH)

🇺🇸

Bethesda, Maryland, United States

University of Queensland

🇦🇺

Brisbane St Lucia, Queensland, Australia

Tel-Aviv University

🇮🇱

Tel-Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath